'MyBioPharmaSpace'

Merck has announced it will partner with non-profit research organisation Omico and its groundbreaking national population screening and clinical trial network.

New Zealand's Coalition Government has adopted a 12-month prescription duration policy, which it estimates will cost NZ$91 million over four years, as more medicines are expected to be dispensed.

"Mark Butler has a mammoth task, now that he has responsibility for the NDIS, but he has committed to HTA reform. There is an opportunity for him to be more directive to officials, which is something we might need," said Medicines Australia chief executive Liz de Somer.

The TGA has approved a new medicine that works to remove the build-up of a protein in the brain that can lead to memory loss and impaired thinking.

The Medicines Australia chair rightly called for product case studies. Companies should provide them, but also be prepared to defend them, because history suggests the Government and its officials will scrutinise and test each example.

According to the Trump administration's plan, its "immediate steps" to implement the 'MFN' policy essentially amount to asking companies to align the prices paid in the US with those in comparable countries.

"As Minister, I have a responsibility to ensure NDIS is not done to or for participants without their input," said NDIS Minister Senator Jenny McAllister.

The Commonwealth has embarked on a significant collection of 'uncertified' PBS claims, with medicine suppliers receiving surprise invoices totalling hundreds of millions of dollars.

The Medicines Australia leadership is articulating a more assertive stance on change based on the public statements of its chair and chief executive.

Bellberry’s CEO, Kylie Sproston, said the 2024 data show that Australia is uniquely positioned to attract global investment in clinical trials due to the high quality of its healthcare institutions and researchers.

Australian experts are urging greater vigilance and awareness of RSV among older adults, particularly grandparents caring for young grandchildren, ahead of the winter season.

The US has cleared for marketing the first in vitro diagnostic device that tests blood to aid in the diagnosis of Alzheimer’s disease.